Status:
COMPLETED
Prebiotic Supplementation and Intestinal Barrier Function in Elderly: a RCT
Lead Sponsor:
Örebro University, Sweden
Collaborating Sponsors:
Fibebiotics consortium (EU)
Conditions:
Prebiotics
Aged
Eligibility:
All Genders
55+ years
Phase:
NA
Brief Summary
The investigators aim was to assess whether 6 weeks of oral intake of the wheat-derived prebiotic fiber arabinoxylan or oat-derived beta-glucan could improve intestinal barrier function against drug-i...
Detailed Description
The study consisted of a 9 week clinical trial to which the study participants orally ingested two different prebiotic compounds/one placebo for a total of 6 weeks. The primary outcome was intestinal...
Eligibility Criteria
Inclusion
- Informed consent signed by study participant
- Age ≥ 55 years
- Mentally and physically fit to complete questionnaires during the study period
Exclusion
- Known or genic gastrointestinal disease, with strictures, malignance's and ischemia.
- Inflammatory bowel diseases (IBD)
- Participation in other clinical trials in the past three months.
- Intake of medications know to change the inflammatory status (i.e proton pump inhibitors, antibiotic, anti-inflammatory medication (including NSAIDs)
Key Trial Info
Start Date :
October 12 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 18 2015
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03336385
Start Date
October 12 2015
End Date
December 18 2015
Last Update
August 23 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Örebro University
Örebro, Sweden, 701 82